Clinical use of oral antihistamines and intranasal corticosteroids in patients with allergic rhinitis

Journal of Investigational Allergology and Clinical Immunology

Volumn 21, Issue 5, 2011, Pages 363-369

  Navarro, A ^a   Valero, A ^b   Rosales, M J ^c   Mullol, J ^d  

^a Hospital El Tomillar   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Allergic rhinitis; Intranasal corticosteroids; Oral antihistamines; Treatment

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID;

ADULT; ALLERGIC RHINITIS; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE CONTROL; DISEASE DURATION; DISEASE SEVERITY; DRUG PREFERENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PATIENT PREFERENCE; PATIENT SATISFACTION; PHYSICIAN ATTITUDE; RECOMMENDED DRUG DOSE; TREATMENT DURATION; VISUAL ANALOG SCALE;

ADRENAL CORTEX HORMONES; ADULT; ALLERGENS; HISTAMINE ANTAGONISTS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT PREFERENCE; PATIENT SATISFACTION; PHYSICIAN'S PRACTICE PATTERNS; POACEAE; POLLEN; PRACTICE GUIDELINES AS TOPIC; PRESCRIPTIONS; QUESTIONNAIRES; RHINITIS, ALLERGIC, SEASONAL; SPAIN;

EID: 80051759224     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Mullol J, Valero A, Alobid I, Bartra J, Navarro AM, Chivato T, Khaltaev N, Bousquet J. Allergic Rhinitis and its Impact on Asthma Update (ARIA 2008). The perspective from Spain. J Invest Allergol Clin Immunol. 2008;18:327-34.
2. Valero A, Alonso J, Antépara I, Baró E, Colás C, del Cuvillo A, Ferrer M, Herdman M, Marti-Guadaño E, Monclús L, Navarro-Pulido AM, Sastre J, Izquierdo I, Mullol J. Health-related quality of life in allergic rhinitis: comparing the short form ESPRINT-15 and MiniRQLQ questionnaires. Allergy. 2007;62:1372-8.
3. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, Agache I, Aït-Khaled N, Bachert C, Blaiss MS, Bonini S, Boulet LP, Bousquet PJ, Camargos P, Carlsen KH, Chen Y, Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, van Wijk RG, Kalayci O, Kaliner MA, Kim YY, Kowalski ML, Kuna P, Le LT, Lemiere C, Li J, Lockey RF, Mavale-Manuel S, Meltzer EO, Mohammad Y, Mullol J, Naclerio R, O'Hehir RE, Ohta K, Ouedraogo S, Palkonen S, Papadopoulos N, Passalacqua G, Pawankar R, Popov TA, Rabe KF, Rosado-Pinto J, Scadding GK, Simons FE, Toskala E, Valovirta E, van Cauwenberge P, Wang DY, Wickman M, Yawn BP, Yorgancioglu A, Yusuf OM, Zar H, Annesi-Maesano I, Bateman ED, Ben Kheder A, Boakye DA, Bouchard J, Burney P, Busse WW, Chan-Yeung M, Chavannes NH, Chuchalin A, Dolen WK, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Keith PK, Kemp JP, Klossek JM, Larenas-Linnemann D, Lipworth B, Malo JL, Marshall GD, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP, Potter P, Price D, Stoloff SW, Vandenplas O, Viegi G, Williams D; World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63 (Suppl. 86):8-160.
4. Scadding GK, Durham SR, Mirakian R, Jones NS, Leech SC, Farooque S, Ryan D, Walker SM, Clarkz AT, Dixon TA, Jolles SRA, Siddique N, Cullinan P, Howarth PH, Nasser SM. BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin Exp Allergy. 2008;38:19-42.
5. Juniper EF, Kline PA, Hargreave FE, Dolovich J. Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis. J Allergy Clin Immunol. 1989;83:627-33.
6. Benincasa C, Lloyd RS. Evaluation of fl uticasone propionate aqueous nasal spray taken alone and in combination with cetirizine in the prophylactic treatment of seasonal allergic rhinitis. Drug Invest. 1994;8:225-33.
7. Simpson RJ. Budesonide and terfenadine, separately and in combination, in the treatment of hay fever. Ann Allergy. 1994;73:497-502.
8. Ratner PH, van Bavel JH, Martin BG, Hampel FC Jr, Howland WC 3rd, Rogenes PR, Westlund RE, Bowers BW, Cook CK. A comparison of the efficacy of fl uticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis. J Fam Pract. 1998;47:118-25.
9. Di Lorenzo G, Pacor ML, Pellitteri ME, Morici G, Di Gregoli A, Lo Bianco C, Ditta V, Martinelli N, Candore G, Mansueto P, Rini GB, Corrocher R, Caruso C. Randomized placebo-controlled trial comparing fl uticasone aqueous nasal spray in mono-therapy, fl uticasone plus cetirizine, fl uticasone plus montelukast and cetirizine plus montelukast seasonal allergic rhinitis. Clin Exp Allergy. 2004;34: 259-67.
10. Barnes ML, Ward JH, Fardon TC, Lipworth BJ. Effects of levocetirizine as add-on therapy to fl uticasone in seasonal allergic rhinitis. Clin Exp Allergy. 2006;36:676-84.
11. Grevers G, Karmann B. Efficacy and safety of Desloratadine and Mometasone furoate Combination Therapy for Seasonal Allergic Rhinitis and Related Sleep Disturbances. Ann Allergy Asthma Immunol 2007;98 (Suppl 1):A92, Abstr P222.
12. Anolik R. Mometasone Furoate Nasal Spray With Loratadine Study Group. Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2008;100:264-71.
13. Andrews CP, Martin BG, Jacobs RL, Mohar DE, Diaz JD, Amar NJ, Kaiser HB, Vandewalker ML. Bernstein J, Toler WT, Prillaman BA, Dalal AA, Lee LA, Philpot EE. Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy. Allergy Asthma Proc. 2009;30:128-38.
14. Nasser M, Fedorowicz Z, Aljufairi H, McKerrow W. Antihistamines used in addition to topical nasal steroids for intermittent and persistent allergic rhinitis in children. Cochrane Database Syst Rev. 2010 Jul 7;7:CD006989.
15. Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonist allergic rhinitis: systematic review of randomised controlled trials. BMJ. 1998;317:1624-9.
16. Kaszuba SM, Barody FM, deTineo M, Haney L, Blair C, Naclerio RM. Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis. Arch Int Med. 2001;161:2581-7.
17. Bhatia S, Baroody FM, de Tineo M, Naclerio RM. Increased nasal airfl ow with budesonide compared with desloratadine during the allergy season. Arch Otolaryngol Head Neck Surg. 2005;131:223-8
18. Benninger M, Farrar JR, Blaiss M, Chipps B, Ferguson B, Krouse J, Marple B, Storm W, Kaliner M. Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class. Ann Allergy Asthma Immunol. 2010;104:13-29.
19. Dalal AA, Stanford R, Henry H, Borah B. Economic burden of rhinitis in managed care: a retrospective claims data analysis. Ann Allergy Asthma Immunol. 2008;101:23-9.
20. Navarro A, Colas C, Antón E, Conde J, Dávila I, Dordal MT, Fernández-Parra B, Ibáñez MD, Lluch-Bernal M, Matheu V, Montoro J, Rondón C, Sánchez MC, Valero A. Rhinoconjunctivitis Committee of the SEAIC. Epidemiology of allergic rhinitis in allergy consultations in Spain: Alergológica-2005. J Investig Allergol Clin Immunol. 2009:19 (suppl 2):7-13.
21. Valero A, Ferrer M, Sastre J, Navarro AM, Monclús L, Martí-Guadaño E, Herdman M, Dávila I, Del Cuvillo A, Colás C, Baró E, Antépara I, Alonso J, Mullol J. A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic Rhinitis and its Impact on Asthma severity items. J Allergy Clin Immunol. 2007;120:359-65.
22. Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, van Wijk RG, Ohta K, Zuberbier T, Schünemann HJ. Global Allergy and Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126:466-76.
23. Howarth PH. A comparison of the anti-infl ammatory properties of intranasal corticosteroids and antihistamines in allergic rhinitis. Allergy. 2000;62:6-11.
24. Prenner BM, Schenkel E. Allergic rhinitis: treatment based on patient profiles. Am J Med. 2006;119:230-7.
25. Bousquet J, Lund VJ, van Cauwenberge P, Bremard-Oury C, Mounedji N, Stevens MT, El-Akkad T. Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial. Allergy. 2003;58:733-41.
26. Van Hoecke H, Vastesaeger N, Dewulf L, De Bacquer D, van Cauwenberge P. Is the Allergic Rhinitis and its Impact on Asthma classification useful in daily primary care practice? J Allergy Clin Immunol. 2006;118:758-9.
27. Keith PK, Scadding GK. Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis? Curr Med Res Opin. 2009;25:2021-41.
28. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004;24:758-64.
29. Mahadevia PJ, Shah S, Leibman C, Kleinman L, O'Dowd L. Patient preferences for sensory attributes of intranasal corticosteroids and willingness to adhere to prescribed therapy for allergic rhinitis: a conjoint analysis. Ann Allergy Asthma Immunol. 2004;93:345-50.
30. Meltzer EO, Stahlman JE, Lefl ein J, Meltzer S, Lim J, Dalai AA, Prillaman BA, Philpot EE. Preferences of adult patients with allergic rhinitis for the sensory attributes of fl uticasone furoate versus fl uticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study. Clin Ther. 2008;30:271-9.
31. Antonicelli L, Micucci C, Voltolini S, Senna GE, Di Blasi P, Visonà G, De Marco R, Bonifazi F. Relationship between ARIA classification and drug treatment in allergic rhinitis and asthma. Allergy. 2007;62:1064-70.
32. Meltzer EO, Nathan RA, Derebery J, Dalal AA, Stanford RH, Corrao MA, McMorris BJ. Physician perceptions of the treatment and management of allergic and nonallergic rhinitis. Allergy Asthma Proc. 2009;30:75-83.
33. Wong IYZ, Soh SE, Chng SY, Shek LP-C, Goh DYT, Van Bever HPS, Lee BW. Compliance with topical nasal medication - an evaluation in children with rhinitis. Pediatr Allergy Immunol. 2010 [Epub ahead of print] [DOI: 10.1111/j.1399-3038.2010.01015.x]
34. Ricard N, Kind P, Christian S, Jensen M, Stewart J. Link between patient preferences and treatment outcomes in seasonal allergic rhinitis: an empiric investigation. Clin Ther. 1999;21:268-77.
35. Mosges R, Koberlein J. New generation antihistamines as monotherapy or in combination. What is the relevance for daily clinical routine for allergic rhinoconjunctivitis? HNO. 2007;55:457-64